Receptor-interacting protein kinase 1 is a key mediator in TLR3 ligand and Smac mimetic-induced cell death and suppresses TLR3 ligand-promoted invasion in cholangiocarcinoma
Abstract Background Toll-like receptor 3 (TLR3) ligand which activates TLR3 signaling induces both cancer cell death and activates anti-tumor immunity. However, TLR3 signaling can also harbor pro-tumorigenic consequences. Therefore, we examined the status of TLR3 in cholangiocarcinoma (CCA) cases to...
Main Authors: | Thanpisit Lomphithak, Swati Choksi, Apiwat Mutirangura, Rutaiwan Tohtong, Tewin Tencomnao, Hajime Usubuchi, Michiaki Unno, Hironobu Sasano, Siriporn Jitkaew |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-10-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12964-020-00661-3 |
Similar Items
-
Key necroptotic proteins are required for Smac mimetic-mediated sensitization of cholangiocarcinoma cells to TNF-α and chemotherapeutic gemcitabine-induced necroptosis.
by: Perawatt Akara-Amornthum, et al.
Published: (2020-01-01) -
Future Therapeutic Directions for Smac-Mimetics
by: Emma Morrish, et al.
Published: (2020-02-01) -
RIPK1‐mediated immunogenic cell death promotes anti‐tumour immunity against soft‐tissue sarcoma
by: Henry G Smith, et al.
Published: (2020-06-01) -
Tumor necroptosis is correlated with a favorable immune cell signature and programmed death-ligand 1 expression in cholangiocarcinoma
by: Thanpisit Lomphithak, et al.
Published: (2021-06-01) -
Seasonality, mediation and comparison (SMAC) methods to identify influences on lung function decline
by: Emrah Gecili, et al.
Published: (2021-01-01)